http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104892573-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44ae178fe5ea1fd193b8e5e1baf1ab3b
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D241-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D241-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-498
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2015-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d38920236c5fa9c41621c593720f44c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2849d4b14abca800746faf7d630682cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f76d77d7d0c579040eb19a35782ecefb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d4a7f1dd5aa27d62e776bb3a529999fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_41c80ad8a4c06dac40bfe36a1e939cff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_040e5e6b17d9adb146ecc21191c09974
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fba0442e411bb47072f2cdb0a65c3b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6dce906bb9c7871d1afa5ac415d0aa8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0486bb31dd3b6b4f227d2381a99a9b05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_009800e802400a499fcd575c764632cb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5455aa1ead8ee6a3ce489f4bc4e686db
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9472a26500a4a04d3ae33bc5f6458d40
publicationDate 2015-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104892573-A
titleOfInvention 3-Vinyl-quinoxalin-2(1H)-one derivatives acting on FGFR-1 and their preparation methods and uses
abstract The invention discloses a 3-vinyl-quinoxalin-2(1H)-one derivative acting on FGFR-1, a preparation method and application thereof, and belongs to the field of medicinal chemistry. The present invention uses o-phenylenediamine and pyruvic acid as raw materials to obtain 3-methylquinoxalin-2(1H)-one through cyclization, and then reacts with different substituted aldehydes to obtain 3-substituted quinoxaline derivatives, and Using this as an intermediate product to obtain other types of target compounds through substitution, a total of 6 new compounds have been prepared in the present invention. The 3-vinyl-quinoxalin-2(1H)-one derivatives of the present invention have a certain inhibitory effect on experimental cells, exhibit certain anti-tumor activity, have selectivity to cells, and have good safety and Kinase inhibitory activity.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111675665-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108752325-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112645891-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108752325-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112645891-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110627733-A
priorityDate 2015-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H01287077-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421200779
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466364887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433035972
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415742933
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154443698
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7236
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421057179
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7241
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69523

Total number of triples: 42.